Adenovirus-mediated transfer of p33(ING1) with p53 drastically augments apoptosis in gliomas

Cancer Research

Volumn 59, Issue 21, 1999, Pages 5521-5528

  Shinoura, Nobusada ^a,b   Muramatsu, Yukiko ^a   Nishimura, Miyako ^a   Yoshida, Yoko ^a   Saito, Atsushi ^c   Yokoyama, Tadaaki ^c   Furukawa, Toru ^c   Horii, Akira ^c   Hashimoto, Mitsuhiro ^d   Asai, Akio ^b   Kirino, Takaaki ^b,e   Hamada, Hirofumi ^a,e  

^a CANCER INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^e SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN BASIC PROTEIN; PROTEIN P53;

ADENOVIRUS; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE INDUCTION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL CYCLE PROTEINS; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER TECHNIQUES; GENES, TUMOR SUPPRESSOR; GLIOMA; HUMANS; IMMUNOBLOTTING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LAC OPERON; MITOCHONDRIA; MYELIN BASIC PROTEINS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 0033230641     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Fujiwara, T., Cai, D. W., Georges, R. N., Mukhopadhyay, T., Grimm, E. A., and Roth, J. A. Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model. J. Natl. Cancer Inst., 86: 1458-1462, 1994.
2. Liu, T. J., Zhang, W. W., Taylor, D. J., Roth, J. A., Goepfert, H., and Clayman, G. L. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res., 54: 3662-3667, 1994.
3. Asai, A., Miyagi, Y., Sugiyama, A., Gamanuma, M., Hong, S. H., Takamoto, S., Nomura, K., Matsutani, M., Takakura, K., and Kuchino, Y. Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy. J. Neurooncol., 19: 259-268, 1994.
4. Badie, B., Drazan, K. E., Kramar, M. H., Shaked, A., and Black, K. L. Adenovirus-mediated p53 gene delivery inhibits 9L glioma growth in rats. Neurol. Res., 17: 209-216, 1995.
5. Kock, H., Harris, M. P., Anderson, S. C., Machmer, T., Hancock, W., Sutjipto, S., Wills, K. N., Gregory, R. J., Shepard, H. M., Westphal, M., and Maneval, D. C. Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo. Int. J. Cancer, 67: 808-815, 1996.
6. Roth, J. A., Nguyen, D., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Ferson, D. Z., Hong, W. K., Komaki, R., Lee, J. J., Nesbitt, J. C., Pisters, K. M., Putnam, J. B., Schea, R., Shin, D. M., Walsh, G. L., Dolormente, M. M., Han, C. I., Martin, F. D., Yen, N , Xu, K., Stephens, L. C., McDonnell, T. J., Mukhopadhyay, T., and Cai, D. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat. Med., 2: 985-991, 1996.
7. Pirollo, K. F., Hao, Z., Rait, A., Jang. Y. J., Fee, W. E., Jr., Ryan, P., Chiang, Y., and Chang, E. H. p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy. Oncogene, 14: 1735-1746, 1997.
8. Spitz, F. R., Nguyen, D., Skibber, J. M., Meyn, R. E., Cristiano, R. J., and Roth, J. A. Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation. Clin. Cancer Res., 2: 1665-1671, 1996.
9. Badie, B., Kramar, M. H., Lau, R., Boothman, D. A., Economou, J. S., and Black, K. L. Adenovirus-mediated p53 gene delivery potentiates the radiation-induced growth inhibition of experimental brain tumors. J. Neurooncol., 37: 217-222, 1998.
10. Yang, B., Eshleman, J. R., Berger, N. A., and Markowitz, S. D. Wild-type p53 protein potentiates cytotoxicity of therapeutic agents in human colon cancer cells. Clin. Cancer Res., 2: 1649-1657, 1996.
11. Ogawa, N., Fujiwara, T., Kagawa, S., Nishizaki, M., Morimoto, Y., Tanida, T., Hizuta, A., Yasuda, T., Roth, J. A., and Tanaka, N. Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent. Int. J. Cancer, 73: 367-370, 1997.
12. Dorigo, O., Turla, S. T., Lebedeva, S., and Gjerset, R. A. Sensitization of rat glioblastoma multiforme to cisplatin in vivo following restoration of wild-type p53 function. J. Neurosurg., 88: 535-540, 1998.
13. Mukhopadhyay, T., and Roth, J. A. Superinduction of wild-type p53 protein after 2-methoxyestradiol treatment of Ad5p53-transduced cells induces tumor cell apoptosis. Oncogene, 17: 241-246, 1998.
14. Sandig, V., Brand, K., Herwig, S., Lukas, J., Bartek, J., and Strauss, M. Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nat. Med., 3: 313-319, 1997.
15. Putzer, B. M., Bramson, J. L., Addison, C. L., Hitt, M., Siegel, P. M., Muller, W. J., and Graham, F. L. Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer. Hum. Gene Ther., 9: 707-718, 1998.
16. Tanaka, N., Ishihara, M., Lamphier, M. S., Nozawa, H., Matsuyama, T., Mak. T. W., Aizawa, S., Tokino, T., Oren, M., and Taniguchi, T. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature (Lond.), 382: 816-818, 1996.
17. Maheswaran, S., Englert, C., Bennett, P., Heinrich, G., and Haber, D. A. The WTI gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev., 9: 2143-2156, 1995.
18. Garkavtsev, I., Grigorian, I. A., Ossovskaya, V. S., Chernov, M. V., Chumakov, P. M., and Gudkov, A. V. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature (Lond.), 391: 295-298, 1998.
19. Helbing, C. C., Veillette, C., Riabowol, K., Johnston, R. N., and Garkavtsev, I. A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis. Cancer Res., 57: 1255-1258, 1997.
20. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
21. Raycroft, L., Wu, H. Y., and Lozano, G. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science (Washington DC), 249: 1049-1051, 1990.
22. Miyashita, T., and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80: 293-299, 1995.
23. Owen-Schaub, L. B., Zhang, W., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A. B., Zhang, W-W., Kruzel, E., and Radinsky, R. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol., 15: 3032-3040, 1995.
24. Haupt, Y., Rowan, S., Shaulian, E., Kazaz, A., Vousden, K., and Oren, M. p53 mediated apoptosis in HeLa cells: transcription dependent and independent mechanisms. Leukemia (Baltimore), 11: 337-339, 1997.
25. Miyao, Y., Shimizu, K., Moriuchi, S., Yamada, M., Nakahara, K., Nakajima, K., Nakao, J., Kuriyama, S., Tsujii, T., Mikoshiba, K., Hayakawa, T., and Ikenaka, K. Selective expression of foreign genes in glioma cells: use of the mouse myelin basic protein gene promoter to direct toxic gene expression. J. Neurosci. Res., 36: 472-479, 1993.
26. Miyao, Y., Shimizu, K., Tamura, M., Akita, H., Ikeda, K., Mabuchi, E., Kishima, H., Hayakawa, T., and Ikenaka, K. Usefulness of a mouse myelin basic protein promoter for gene therapy of malignant glioma: myelin basic protein promoter is strongly active in human malignant gliomas. Jpn. J. Cancer Res., 88: 678-686, 1997.
27. Miura, M., Tamura, T., Aoyama, A., and Mikoshiba, K. The promoter elements of the mouse myelin basic protein gene function efficiently in NG108-15 neuronal/glial cells. Gene (Amst.), 75: 31-38, 1989.
28. Hashimoto, M., Aruga, J., Hosoya, Y., Kanegae, Y., Saito, I., and Mikoshiba, K. A neural cell-type-specific expression system using recombinant adenovirus vectors. Hum. Gene Ther., 7: 149-158, 1996.
29. Mori, Y., Shiwaku, H., Fukushige, S., Wakatsuki, S., Sato, M., Nukiwa, T., and Horii, A. Alternative splicing of hMSH2 in normal human tissues. Hum. Genet., 99: 590-595, 1997.
30. Yoshida, Y., and Hamada, H. Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal. Biochem. Biophys. Res. Commun., 230: 426-430, 1997.
31. Miyake, S., Makimura, M., Kanegae, Y., Harada, S., Sato, Y., Takamori, K., Tokuda, C., and Saito, I. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. USA, 93: 1320-1324, 1996.
32. Yoshida, Y., Sadata, A., Zhang, W., Saito, K., Shinoura, N., and Hamada, H. Generation of fiber-mutant recombinant adenoviruses for gene therapy of malignant glioma. Hum. Gene Ther., 9: 2503-2515, 1998.
33. Kanegae, Y., Lee, G., Sato, Y., Tanaka, M., Nakai, M., Sakaki, T., Sugano, S., and Saito, I. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res., 23: 3816-3821, 1995.
34. Sato, N., Wang, S., Li, L., Okabe, K., Hashimoto, M., Yaginuma, H., Mikoshiba, K., Uchiyama, Y., Uetsuki, T., Yoshikawa, K., Milligan, C. E., and Oppenheim, R. W. A novel strategy for introducing exogenous bcl-2 into neuronal cells: the Cre/loxP system-mediated activation of bcl-2 for preventing programmed cell death using recombinant adenoviruses. Mol. Cell. Neurosci., 12: 65-78, 1998.
35. Mayama, T., Mori, T., Abe, K., Sasano, H., Nishihira, T., Satomi, S., and Horii, A. Analysis of the p53 gene mutations in patients with multiple primary cancers of the oesophagus. Eur. J. Surg. Oncol., 23: 298-303, 1997.
36. Shinoura, N., Yoshida, Y., Sadata, A., Hanada, K., Yamamoto, S., Kirino, T., Asai, A., and Hamada, H. Apoptosis by retrovirus- and adenovirus-mediated gene transfer of Fas ligand to glioma cells: implications for gene therapy. Hum. Gene Ther., 9: 1983-1993, 1998.
37. Mosner, J., Mummenbrauer, T., Bauer, C., Sczakiel, G., Grosse, F., and Deppert, W. Negative feedback regulation of wild-type p53 biosynthesis. EMBO J., 14: 4442-4449, 1995.
38. Wolozin, B., Iwasaki, K., Vito, P., Ganjei, J. K., Lacana, E., Sunderland, T., Zhao, B., Kusiak, J. W., Wasco, W., and D'Adamio, L. Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science (Washington DC), 274: 1710-1713, 1996.
39. Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., and Vogelstein, B. A model for p53-induced apoptosis. Nature (Lond.), 389: 300-305, 1997.
40. ING1 promotes neoplastic transformation. Nat. Genet., 14: 415-420, 1996.
41. Garkavtsev, I., Demetrick, D., and Riabowol, R. Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (INGI). Cytogenet. Cell Genet., 76: 176-178, 1997.
42. Zeremski, M., Horrigan, S. K., Grigorian, I. A., Westbrook, C. A., and Gudkov, A. V. Localization of the candidate tumor suppressor gene INGI to human chromosome 13q34. Somat. Cell. Mol. Genet., 23: 233-236, 1997.
43. ING1 candidate tumor suppressor. Mol. Cell. Biol., 17: 2014-2019, 1997.
44. Joshi, U. S., Chen, Y. Q., Kalemkerian, G. P., Adil, M. R., Kraut, M., and Sarkar, F. H. Inhibition of tumor cell growth by p21WAF1 adenoviral gene transfer in lung cancer. Cancer Gene Ther., 5: 183-191, 1998.
45. Eastham, J. A., Hall, S. J., Sehgal, J., Wang, J., Timme, T. L., Yang, G., Connell-Crowley, L., Elledge, S. J., Zhang, W. W., Harper, J. W., and Thompson, T. C. In vivo gene therapy with p53 or p21 adenovirus for prostate cancer. Cancer Res., 55: 5151-5155, 1995.
46. Davidoff, A. M., Pence, J. C., Shorter, N. A., Iglehart, J. D., and Marks, J. R. Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines. Oncogene, 7: 127-133, 1992.
47. Jordan, J., Galindo, M. F., Prehn, J. H., Weichselbaum, R. R., Beckett, M., Ghadge, G. D., Roos, R. P., Leiden, J. M., and Miller, R. J. p53 expression induces apoptosis in hippocampal pyramidal neuron cultures. J. Neurosci., 17: 1397-1405, 1997.